Nutlin-3a Essentials Characterized

5A, 5B) differs from what we observed in irradiated hosts (Fig. 4). In nonirradiated hosts, at 2 weeks post-transplantation, over half of the donor cells were lacking host MHC class I proteins (H-2Kd) (56.5%, range: 55%�C58%) (Fig. 5A). This single H-2Kb+ donor cell population persisted for 8 weeks post-transplantation (61.5%, range: 61%�C62%) (Fig. 5B). Without irradiation, macrophages in NOD/SCID/gamma mice were not activated and were unable to eliminate single H-2Kb+ donor cells. Therefore, the population of cells that has not undergone trogocytosis would survive and proliferate, resulting in a larger portion of single H-2Kb+ donor cells compared to irradiated hosts during the early stages of engraftment. Moreover, these results reinforce that trogocytosis is a natural cellular event and not a by-product of irradiation. To confirm that macrophages are responsible for the rejection of single H-2Kb+ donor cells in irradiated NOD/SCID/gamma hosts, the hosts http://www.selleckchem.com/products/AC-220.html were pretreated with gadolinium chloride (GdCl3) before irradiation and transplantation. GdCl3 inhibits phagocytosis and eliminates macrophages [[19]]. Irradiated NOD/SCID/gamma hosts pretreated with GdCl3 http://www.selleck.cn/products/Romidepsin-FK228.html had a different donor cell composition than irradiated but nontreated hosts (Fig. 4: untreated vs. Fig. 5C: GdCl3-treated). GdCl3-treated hosts were more tolerant of single H-2Kb+ donor cells with 42% (range: 34%�C50%) of the donor cells being single positive at 1 week post-transplantation, while the irradiated but nontreated hosts had 24% (range: 20%�C27%) single H-2Kb+ donor cells. This difference was statistically significant (p http://www.selleckchem.com/products/nutlin-3a.html mice, and as expected trogocytosis-positive human donor cells were protected from destruction during engraftment. Human cells colonized the recipient mice at a slower rate than mouse donor cells did, but we observed at 1 week post-transplantation that donor cells contributed approximately 3% (range: 2.5%�C3.7%) of the total cells and approximately 88% (range: 81%�C93%) of these cells was trogocytosis-positive (range: 83%�C94%) (Fig. 6A). By the second week, donor cell contribution increased to approximately 12% (range: 1.